Fluorescent gel used in vampire bats could be effective rabies control

Nov. 18, 2019
The fluorescent gel was applied to wild vampire bats at three colonies in Peru, where it simulated the bat-to-bat spread of an orotopical rabies vaccine.

A team of researchers at the University of Michigan (Ann Arbor, MI) and the University of Glasgow (Glasgow, Scotland) used glowing fluorescent gel to test the potential effectiveness of vaccines to control rabies and other diseases in wild bats. The team's study found that a low-effort vaccination program could substantially reduce rabies transmission in wild vampire bats, thereby reducing the risk of lethal infections in humans and livestock.

The gel, which contained a fluorescent tracer dye called Rhodamine B, was applied to wild vampire bats at three colonies in Peru, where it simulated the bat-to-bat spread of an orotopical rabies vaccine. Such vaccines, which are applied orally or topically and are then spread between bats through oral contact during grooming, have already been shown to protect multiple bats against rabies for every individual vaccinated in the laboratory, but their levels of spread in wild bats was unknown until now.

When the gel was ingested by bats that groomed each other, it led to fluorescence in the bats' hair follicles, which was then monitored by fluorescence microscopy of hair samples collected by the scientists.

The study demonstrated that because of bat-to-bat transfer, orotopical rabies vaccines would protect 2.6 bats for every bat that's vaccinated, compared to a single bat protected by conventional nonspreadable vaccines.

The researchers used mathematical models to show that observed levels of vaccine transfer would reduce the probability, size, and duration of rabies outbreaks, even at low but realistically achievable levels of vaccine deployment. The models further showed that a spreadable vaccine would control rabies more effectively than the current policy of killing the bats with a poisonous gel that spreads by the same route of contact and grooming.

"We demonstrate why over 40 years of culling vampire bats has failed to contain the disease in Latin America," says Kevin Bakker, a postdoctoral researcher in the University of Michigan's Department of Statistics and the lead author of the study. "Our mathematical models reveal that bats would have to be effectively eliminated to reduce rabies more efficiently than vaccines, and our field studies imply that this level of culling effort is not practically attainable in real-world campaigns."

Existing management strategies have been unable to mitigate the burden of rabies, with uptake of protective vaccines for humans and livestock limited by high costs and inaccessibility to remote areas. Another strategy, poisoning the bats to reduce their populations, is controversial and has had mixed results for rabies control.

"Vampire bat rabies still has severe medical and agricultural impacts across North, Central, and South America despite decades of efforts to mitigate its burden. Our findings demonstrated that bat-to-bat transfer of oral rabies vaccines could increase population-level immunity up to 2.6 times beyond the same effort using conventional, non-spreadable vaccines," says Daniel Streicker, senior author of the paper and a senior research fellow at the University of Glasgow's Institute of Biodiversity, Animal Health & Comparative Medicine and the MRC-University of Glasgow Centre for Virus Research.

"Until recently, controlling diseases in reclusive animals like wild bats seemed unimaginable. Our findings reveal the exciting potential for using a new generation of spreadable vaccine technologies to protect human and animal health by fighting diseases within their wildlife hosts," Streicker adds.

Because rabies relies on vampire bat movement between colonies, a strategic switch from poisoning to vaccination would increase immunity and may lead to a dramatic reduction in rabies across Latin America, Bakker says.

Full details of the work appear in the journal Nature Ecology & Evolution.

Source: November 18, 2019 EurekAlert news release

Got biophotonics-related news to share with us? Contact Lee Dubay, Associate Editor, BioOptics World

Get even more news like this delivered right to your inbox

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Manufacturing thin films with tailor-made electronic properties

Dec. 5, 2023
Unlock the future of optoelectronics as researchers at Leibniz IPHT in Jena, Germany unveil an innovative technique for precision deposition of thin organic semiconductor films...

Quantitative Microscopy with Deep Learning

Dec. 5, 2023
Explore the untapped potential of deep learning in video microscopy with our cutting-edge software, DeepTrack 2.2. Overcoming the steep learning curve, this innovative application...

Stimulated Brillouin scattering enhances CMOS chip for microwave signal processing

Dec. 5, 2023
University of Sydney Nano Institute researchers are pioneering photonic silicon chips and helping spur growth in Australia’s semiconductor industry.

Current Trends in Laser Absorption Spectroscopy: More than Just Beer's Law

Dec. 5, 2023
Dive into the cutting-edge world of absorption spectroscopy in our upcoming webinar, exploring groundbreaking techniques such as cavity ringdown spectroscopy, photoacoustic spectroscopy...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!